Discovery of a degrader for AML differentiation therapy

ABSTRACT: NB4 cells were treated with the 250 nM RPOTAC molecule CPS2 for 6 h before cell lysis. CDK2 stood out as the most down-regulated target.Quantitative analysis of the cells after treatment.

ORGANISM(S): Homo Sapiens

SUBMITTER: Yu Rao  

PROVIDER: PXD021592 | iProX | Mon Sep 21 00:00:00 BST 2020

REPOSITORIES: iProX